Youtoons Describe Obama Care in a Simple Video

The new Health Care law (Obamacare) is scheduled to take effect in 2014 with the first open enrollment period beginning on October 1, 2013. That is only 2 months away! We all have hear the constant din about the new law, but most of us don't have the slightest understanding of how it will work. [...]

Increasing Cost of Treating Men with Advanced Prostate Cancer & Its Effects on the Payers

The treatment of advanced prostate cancer, and in particular castrate resistant prostate cancer (CRPC), has changed greatly over the last 4 years. Treatment options have expanded and now offer multiple treatment possibilities that did not exist 4 years ago. With the addition of all these new options, so comes the addition of significant economic costs, [...]

An Important Note for Residents of New York State -Ask Governor Cuomo to Sign the Oral Chemotherapy Equity Bill

There is some good news; the New York State Legislature has passed the Oral Chemotherapy Equity Bill. However, before this bill can become law we have to have Governor Cuomo sign it, we need all of our New York Residents to contact the governor and ask that he signs it. […]

Provenge Receives A Positive National Determination from CMS

Yesterday Dendreon, the producers of Provenge, received word from the FDA that their plant in California had been approved to manufacture Provenge. This afternoon they received a positive response from the Centers for Medicare and Medicaid Services (CMS) that a final National Coverage Decision (NCD) for Provenge has been issued requiring Medicare contractors to cover [...]

A Note from Chuck- An Expansion of Naval Vessels with Agent Orange Exposure Making VA Benefits Available to Additional Men

The Naval Fleet Reserve Association recently provided the following information regarding updates of the Veterans Administration list of vessels exposed to Agent Orange during the Vietnam conflict. This will include many more veterans eligible for VA care for the many diseases attributed to this product. […]

Go to Top